Acadia Pharmaceuticals
|
14.66 |
|
-0.07 |
-0.48% |
-14.27% |
2025-04-28 |
Agios Pharmaceuticals
|
29.60 |
|
0.15 |
0.51% |
-9.65% |
2025-04-28 |
Alnylam Pharmaceuticals
|
254.97 |
|
3.41 |
1.36% |
73.03% |
2025-04-28 |
Amgen
|
283.39 |
|
2.66 |
0.95% |
2.53% |
2025-04-28 |
Biogen
|
119.12 |
|
0.29 |
0.24% |
-44.68% |
2025-04-28 |
BioMarin Pharmaceutical
|
62.98 |
|
-0.32 |
-0.51% |
-23.32% |
2025-04-28 |
Bristol-Myers Squibb
|
48.46 |
|
0.61 |
1.27% |
8.58% |
2025-04-28 |
Exelixis
|
38.44 |
|
1.01 |
2.70% |
61.99% |
2025-04-28 |
Gilead Sciences
|
106.36 |
|
3.23 |
3.13% |
61.47% |
2025-04-28 |
Incyte
|
59.52 |
|
0.36 |
0.61% |
13.35% |
2025-04-28 |
Ionis Pharmaceuticals
|
29.74 |
|
0.04 |
0.13% |
-29.17% |
2025-04-28 |
Eli Lilly
|
878.86 |
|
-5.98 |
-0.68% |
19.26% |
2025-04-28 |
MacroGenics
|
1.64 |
|
-0.07 |
-4.09% |
-88.93% |
2025-04-28 |
Merck
|
83.32 |
|
0.50 |
0.60% |
-35.89% |
2025-04-28 |
Moderna
|
27.49 |
|
0.31 |
1.14% |
-75.37% |
2025-04-28 |
Neurocrine Biosciences
|
106.46 |
|
-0.27 |
-0.25% |
-23.35% |
2025-04-28 |
Novartis
|
93.40 |
|
0.86 |
0.93% |
5.10% |
2025-04-28 |
Novartis
|
112.68 |
|
1.46 |
1.31% |
13.66% |
2025-04-28 |
Pfizer
|
23.07 |
|
0.13 |
0.57% |
-9.85% |
2025-04-28 |
PTC Therapeutics
|
49.74 |
|
0.21 |
0.42% |
54.76% |
2025-04-28 |
Ultragenyx Pharmaceutical
|
37.95 |
|
-0.14 |
-0.37% |
-13.79% |
2025-04-28 |
Regeneron Pharmaceuticals
|
612.04 |
|
9.86 |
1.64% |
-31.34% |
2025-04-28 |
Sarepta Therapeutics
|
61.51 |
|
1.07 |
1.77% |
-52.24% |
2025-04-28 |
Vertex Pharmaceuticals
|
496.84 |
|
3.03 |
0.61% |
25.54% |
2025-04-28 |